Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1854 of 5804
-
New Self-Locking biceps repair could reduce popeye deformity after rotator cuff surgery
Disease control Recruiting nowThe aim of this study is to compare the clinical results and complications of self-locking biceps tenodesis and double 360 lasso loop biceps tenodesis for the treatment of long chief of biceps or superior labrum anterior-posterior (SLAP) tendon pathology during shoulder arthrosco…
Phase: NA • Sponsor: Clinique Générale dAnnecy • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Gut bacteria clues may unlock long COVID mysteries
Knowledge-focused Recruiting nowThe SARS-CoV-2 virus causes COVID-19, which ranges from mild initial symptoms to severe multi-organ dysfunction. While some patients recover to their baseline states, others develop a long COVID, or post-acute sequelae of SARS-CoV-2 (PASC) consisting of symptoms persisting \>2-6 …
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Exercise program aims to boost both body and mind in multiple sclerosis
Disease control Recruiting nowThis project involves two sub-parts: Study 1: Effect of lab-based Functional Balance Intervention (FBI) for physical and cognitive symptoms of Multiple Sclerosis. Study 2: Feasibility of home-based FBI for physical and cognitive symptoms of Multiple Sclerosis. Each study invol…
Phase: NA • Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Needle-Free COVID-19 vaccine shows promise in early trial
⭐️ VACCINE ⭐️ CompletedCOV2 is a nasal, investigational vaccine against COVID-19, based on a serotype 5 adenoviral vector producing the SARS-CoV-2 spike protein. In this trial, the primary comparison in terms of safety and immunogenicity will be between two different dose levels of COV2 booster vaccine…
Phase: PHASE1 • Sponsor: Rokote Laboratories Finland Oy • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:02 UTC
-
Massive study of 22 million seniors tests pneumonia Vaccine's Real-World power
⭐️ VACCINE ⭐️ OngoingThe purpose of this study is to learn about how well the Prevnar 20 vaccine (PCV20) stops invasive pneumococcal disease (a group of severe infections caused by a bacteria called Streptococcus pneumoniae), pneumococcal pneumonia (a bacterial lung disease caused by the germ Strepto…
Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:23 UTC
-
New ultrasound dye could help detect childhood liver cancer earlier
Diagnosis Recruiting nowLiver tumours, 40% of which are benign, account for 1% to 4% of all solid tumours in children. The benign tumours are mainly haemangiomas, liver hamartomas, and liver cell adenomas. The malignant tumours are mainly hepatoblastoma, hepatocellular carcinoma (HCC), malignant liver m…
Phase: PHASE4 • Sponsor: GE Healthcare • Aim: Diagnosis
Last updated Jun 27, 2026 09:10 UTC
-
Leg artery showdown: bypass vs. balloon for blockages
Disease control Recruiting nowIn lower limb peripheral arterial disease, the stage of intermittent claudication has a prevalence of more than 5% over the age of 60, and affects patients who are often still active. Frequent anatomical lesions are strictures / occlusions of the superficial femoral artery. Ther…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
MRNA vaccine takes on Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis study aims to investigate the safety and efficacy of the IL-22BP/LNP compound in patients with refractory malignant solid tumors, such as advanced soft tissue sarcoma, advanced head and neck squamous cell carcinoma, and malignant melanoma, who have failed second-line treatme…
Phase: PHASE1 • Sponsor: Xingchen Peng • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New laser may zap kidney stones faster and safer
Disease control Recruiting nowThe goal of this prospective, multicenter, randomized controlled trial is to objectively evaluate the clinical efficacy and safety differences between superpulse thulium fiber laser (sTFL) and holmium:YAG laser (Ho:YAG) in flexible ureteroscopy (FURS) lithotripsy in adult patient…
Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Doula-Delivered therapy and heart health coaching aims to protect new moms
Disease control OngoingLHMoms is a novel integrated care intervention that focuses intensively on care continuity and community-to-healthcare linkages for postpartum birthing individuals. The intervention starts prior to discharge in the delivery hospitalization and extends to six months post-partum, t…
Phase: NA • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Simple arm exercises may boost dialysis access success for kidney patients
Disease control Recruiting nowFor patients living with Chronic Kidney Disease who are preparing to start hemodialysis, having a well-functioning arteriovenous fistula (AVF) is essential. Although the AVF is considered the best type of vascular access, its maturation process does not always go as expected-stud…
Phase: NA • Sponsor: Unidade Local de Saúde de Coimbra, EPE • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Oxygen treatment could speed healing of chronic leg sores
Symptom relief Recruiting nowThe purpose of this study is to evaluate the efficacy, safety and economic benefits of Cyclical Pressure Topical Wound Oxygen (TWO2) Therapy in the treatment of venous leg ulcers. Participants will utilize standard of care (SOC) multilayer compression dressings with an inactive w…
Phase: PHASE4 • Sponsor: AOTI Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
New support program aims to boost CPAP use in stroke rehab
Symptom relief Recruiting nowThe SCOUTS 3 study aims to test the effectiveness of an intensive CPAP (Continuous Positive Airway Pressure) therapy support program compared to usual care in stroke patients with obstructive sleep apnea (OSA) during inpatient rehabilitation (IPR). The study is a multicenter ran…
Phase: NA • Sponsor: University of Washington • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
Multitasking training may boost walking after stroke
Symptom relief CompletedWhat is this study about? This study compares two common ways of practicing walking and balance after a stroke: (1) dual-task training, where a person walks or balances while doing a second task (such as counting backward or carrying a light object), and (2) single-task training,…
Phase: NA • Sponsor: University of Lahore • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
Real-world data on multiple myeloma immunotherapies could reshape monitoring and improve survival
Knowledge-focused Recruiting nowThe goal of this observational study is to study the effectiveness and complications of novel immunotherapies used in the treatment of multiple myeloma in routine care in Norway. The aim is to close knowledge gaps, generate evidence for future clinical trials and contribute to fu…
Sponsor: St. Olavs Hospital • Aim: Knowledge-focused
Last updated Jul 22, 2026 00:00 UTC
-
New hope for tough blood cancers? early trial of JNJ-89853413 begins
Disease control OngoingThe purpose of Part 1 (Dose Escalation) of the study is to assess the safety and tolerability, and to identify the recommended Phase 2 dose\[s\] (RP2D\[s\]) in participants with relapsed or refractory (R/R) acute myeloid leukemia (AML) (that is a type of blood cancer that has com…
Phase: PHASE1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Could a new drug beat the standard for preventing postpartum hemorrhage?
Disease control Recruiting nowThe goal of this study is to compare 2 medications that are commonly used to prevent excess uterine bleeding (postpartum hemorrhage, or PPH) following cesarean delivery (CD), oxytocin and carbetocin. Most of the trials evaluating the preventative role of oxytocin and carbetocin a…
Phase: NA • Sponsor: Samuel Lunenfeld Research Institute, Mount Sinai Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Could a light on the forehead ease autism symptoms?
Symptom relief Recruiting nowThe investigators have previously shown that the administration of low-level infrared light is a safe and non-invasive procedure which improves cognition and emotion, as well as enhances brain metabolic activity. Based on previous studies, the investigators hypothesize that this …
Phase: NA • Sponsor: Francisco Gonzalez-Lima, PhD • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Gut bacteria therapy takes on superbugs in new trial
Disease control Recruiting nowREACT is a phase two, open-label, randomized, controlled trial of microbiota therapy (MT) to reduce colonization with multi-drug resistant organisms (MDRO). REACT is designed to assess the safety and efficacy of MT administered to subjects colonized with a MDRO. The overarching h…
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Could growth hormone boost quality of life for brain-injured veterans?
Symptom relief Recruiting nowThe purpose of this study is to determine whether growth hormone replacement therapy (GHRT) is effective versus placebo in the improvement of Quality of Life in patients with adult growth hormone deficiency (AGHD) and mild traumatic brain injury (mTBI).
Phase: PHASE3 • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC